siva604 Posted March 16, 2020 Report Posted March 16, 2020 Trial starting tomorrow https://apnews.com/8089a3d0ec8f9fde971bddd7b3aa2ba1 Quote
siva604 Posted March 16, 2020 Author Report Posted March 16, 2020 2 minutes ago, Narcos said: bought last week fingers crossed Likewise.. atleast its not gonna go down.. Internet world hoping for 100 $ in future, may be mid 30s tomorrow Quote
2020 Posted March 16, 2020 Report Posted March 16, 2020 2 minutes ago, siva604 said: Hoping for moonshot Is it good time to buy MRNA? Quote
siva604 Posted March 16, 2020 Author Report Posted March 16, 2020 Just now, 2020 said: Is it good time to buy MRNA? No one can tell with certainty. Buy some 100 stocks if you want to check your luck.. If premarket shows late 20s better not to enter.. Wait until 11 AM tomorrow Quote
2020 Posted March 16, 2020 Report Posted March 16, 2020 Just now, siva604 said: No one can tell with certainty. Buy some 100 stocks if you want to check your luck.. If premarket shows late 20s better not to enter.. Wait until 11 AM tomorrow Got u...will wait Quote
Narcos Posted March 16, 2020 Report Posted March 16, 2020 6 minutes ago, siva604 said: Likewise.. atleast its not gonna go down.. Internet world hoping for 100 $ in future, may be mid 30s tomorrow Did you buy GILD? @siva604 Quote
HugoStrange Posted March 16, 2020 Report Posted March 16, 2020 buy it if it crosses 31, then it will go to 36. After that your choise. Quote
siva604 Posted March 16, 2020 Author Report Posted March 16, 2020 14 minutes ago, Narcos said: Did you buy GILD? @siva604 just 200 Quote
nag_mama Posted March 16, 2020 Report Posted March 16, 2020 1 hour ago, siva604 said: Trial starting tomorrow https://apnews.com/8089a3d0ec8f9fde971bddd7b3aa2ba1 WASHINGTON (AP) — The first participant in a clinical trial for a vaccine to protect against the new coronavirus will receive an experimental dose on Monday, according to a government official. The National Institutes of Health is funding the trial, which is taking place at the Kaiser Permanente Washington Health Research Institute in Seattle. The official who disclosed plans for the first participant spoke on condition of anonymity because the move has not been publicly announced. Public health officials say it will take a year to 18 months to fully validate any potential vaccine. Testing will begin with 45 young, healthy volunteers with different doses of shots co-developed by NIH and Moderna Inc. There’s no chance participants could get infected from the shots, because they don’t contain the virus itself. The goal is purely to check that the vaccines show no worrisome side effects, setting the stage for larger tests. Dozens of research groups around the world are racing to create a vaccine as COVID-19 cases continue to grow. Importantly, they’re pursuing different types of vaccines — shots developed from new technologies that not only are faster to produce than traditional inoculations but might prove more potent. Some researchers even aim for temporary vaccines, such as shots that might guard people’s health a month or two at a time while longer-lasting protection is developed. Also in the works: Inovio Pharmaceuticals aims to begin safety tests of its vaccine candidate next month in a few dozen volunteers at the University of Pennsylvania and a testing center in Kansas City, Missouri, followed by a similar study in China and South Korea. Even if initial safety tests go well, “you’re talking about a year to a year and a half” before any vaccine could be ready for widespread use, according to Dr. Anthony Fauci, director of NIH’s National Institute of Allergy and Infectious Diseases. That still would be a record-setting pace. But manufacturers know the wait — required because it takes additional studies of thousands of people to tell if a vaccine truly protects and does no harm — is hard for a frightened public. President Donald Trump has been pushing for swift action on a vaccine, saying in recent days that the work is “moving along very quickly” and he hopes to see a vaccine “relatively soon.” Today, there are no proven treatments. In China, scientists have been testing a combination of HIV drugs against the new coronavirus, as well as an experimental drug named remdesivir that was in development to fight Ebola. In the U.S., the University of Nebraska Medical Center also began testing remdesivir in some Americans who were found to have COVID-19 after being evacuated from a cruise ship in Japan. For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia. The worldwide outbreak has sickened more than 156,000 people and left more than 5,800 dead. The death toll in the United States is more than 50, while infections neared 3,000 across 49 states and the District of Columbia. The vast majority of people recover. According to the World Health Organization, people with mild illness recover in about two weeks, while those with more severe illness may take three weeks to six weeks to recover. ___ The Associated Press receives support for health and science coverage from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. Quote
2020 Posted March 17, 2020 Report Posted March 17, 2020 1 hour ago, siva604 said: Patiently waiting for MRNA Enni stocks konnaru....is it good time to buy at 29 Quote
MiryalgudaMaruthiRao Posted March 17, 2020 Report Posted March 17, 2020 Just now, 2020 said: Enni stocks konnaru....is it good time to buy at 29 49 Quote
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.